Form D · Biotechnology
nanoRETE, Inc.
Lansing, MI · CIK 0001565191
Offering snapshot reported Dec 21, 2012 · SEC filing
- Reported sold
- $1.19M Offering amount: $3M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 10, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 21, 2012 | Initial | $1,188,277 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-188894
Source: Form D, filed Dec 21, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Fred Beyerlein | Director, Executive |
| Julia Bradsher | Director |
| Dale Grogan | Director |
| John Kerschen | Director |
| Houng Yau Mei | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
3815 Technology Boulevard Suite 1050
Lansing, MI, 48910
Lansing, MI, 48910